Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 1

2(28.6%)

Phase 4

1(14.3%)

7Total

N/A(4)

Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06328179Not ApplicableRecruiting

Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.

Role: collaborator

NCT06035250Recruiting

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

Role: collaborator

NCT05722275Recruiting

Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics

Role: collaborator

NCT05595096Not ApplicableCompleted

Preservation of Spontaneous Breathing in Patients Undergoing Thoracoscopic Surgery

Role: lead

NCT05567523Phase 4Completed

Safety Study of Dexmedetomidine in Elderly Under General Anesthesia

Role: lead

NCT05253716Not ApplicableRecruiting

Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer

Role: collaborator

NCT05343377Not ApplicableNot Yet Recruiting

A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma

Role: collaborator

NCT01496339Phase 1Unknown

Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

Role: collaborator

NCT01483248Phase 1Unknown

Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis

Role: collaborator

All 9 trials loaded